AEON
AEON Biopharma, Inc.
NYSE MKT: AEON · HEALTHCARE · BIOTECHNOLOGY
$0.95
-3.02% today
Updated 2026-04-29
Market cap
$24.16M
P/E ratio
—
P/S ratio
97.16x
EPS (TTM)
$-3.95
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.5
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$6.70
+601.79%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.71M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | — | $0.00 | $0.00 | $0.00 |
| Net income | $-52.56M | $-384.63M | $42.01M | $-39.22M | $-37.14M |
| EPS | — | — | — | — | $-3.95 |
| Free cash flow | $-35.89M | $-47.83M | $-20.29M | $-17.31M | $-4.71M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
AEON Biopharma, Inc. trades at $0.95. Our Smart Value Score of 17/100 indicates the stock is weak.
Frequently asked questions
What is AEON Biopharma, Inc.'s stock price?
AEON Biopharma, Inc. (AEON) trades at $0.95.
Is AEON Biopharma, Inc. overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of AEON Biopharma, Inc. (AEON)?
The analyst target price is $6.70, representing +601.8% upside from the current price of $0.95.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio97.16x
ROE—
Beta0.74
50D MA$1.05
200D MA$0.95
Shares out0.03B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—